HPLC RESULTS

Our Analytical Commitment to the Australian Research Community

At Peptide Australia, we do not ask researchers to take our word for it. We show them the data. Every research peptide we supply undergoes independent third-party analytical verification before it reaches your laboratory. Furthermore, every result we generate is documented, batch-referenced, and made available for researcher review. This page exists because transparency is not a marketing position at Peptide Australia — it is a scientific standard.

When you buy peptides in Australia through Peptide Australia, you are not simply purchasing a compound. You are purchasing analytical certainty. Our HPLC lab results page gives every researcher, institution, and procurement team direct access to the verification data that underpins every compound in our catalogue.

What Is HPLC and Why Does It Matter for Research Peptides?

High-Performance Liquid Chromatography — HPLC — is the gold standard analytical technique for verifying the purity of research peptides. It is the method used by pharmaceutical manufacturers, university analytical chemistry departments, and accredited independent testing laboratories worldwide to confirm that a compound meets its stated purity specification.

How HPLC Works

HPLC works by passing a dissolved sample through a column packed with a stationary phase material under high pressure. Different components of the sample travel through the column at different rates — depending on their chemical properties and their affinity for the stationary phase. As each component exits the column, a detector measures its presence and generates a signal. The result is a chromatogram — a graphical representation of the sample's composition showing peaks that correspond to each detected component.

For a research peptide, a high-quality HPLC chromatogram shows a single dominant peak representing the target compound. The area of that peak — expressed as a percentage of the total peak area across the chromatogram — gives the purity result. Therefore, a chromatogram showing a single peak occupying 99.2% of the total peak area corresponds to a purity result of 99.2%.

What a ≥99% HPLC Result Means

When Peptide Australia states that a compound meets ≥99% HPLC-verified purity, it means the following specifically:

An independent, accredited third-party laboratory has dissolved a sample from the production batch, passed it through an analytical HPLC column under validated conditions, measured the resulting chromatogram, and calculated that the target compound accounts for a minimum of 99% of the total detected material in the sample.

This is not an estimate. It is not a manufacturer's claim. It is a measured analytical result produced by an independent laboratory using validated instrumentation and methodology — and it is the result we document in the Certificate of Analysis that ships with every order.

What Is Mass Spectrometry and Why Do We Use It Alongside HPLC?

HPLC confirms purity — how much of the compound in the vial is the target compound. Mass Spectrometry confirms identity — that the target compound is actually what it is claimed to be.

How Mass Spectrometry Works

Mass Spectrometry works by ionising the molecules in a sample and measuring their mass-to-charge ratio. Every molecule has a characteristic molecular weight. Therefore, by measuring the mass of the ionised compound, an MS instrument can confirm whether the molecular weight matches the expected value for the target peptide.

For research peptides, this is critical. A compound can pass HPLC purity verification — meaning it is a single dominant component in the sample — while still being the wrong compound if it was incorrectly synthesised or mislabelled. Mass Spectrometry eliminates this risk by independently confirming that the molecular weight and fragmentation pattern of the compound match its exact specified amino acid sequence.

Why Dual Verification Matters

The combination of HPLC purity verification and Mass Spectrometry identity confirmation provides researchers with two independent lines of analytical evidence. Together they confirm both what the compound is and how pure it is. Consequently, when Peptide Australia provides both HPLC and MS results for a batch, researchers receive the most comprehensive analytical assurance available for research peptide supply.

Many Australian peptide suppliers provide one or neither of these verification methods. At Peptide Australia, both are standard — not optional.

Our Verification Process — From Synthesis to Dispatch

Understanding the full verification process that produces our HPLC lab results gives researchers confidence in the integrity of every data point we publish. The following is the complete analytical pathway every Peptide Australia compound travels before dispatch:

Stage 1 — Solid-Phase Peptide Synthesis (SPPS)

Every compound begins with Solid-Phase Peptide Synthesis — the industry gold standard for producing research-grade peptides with precise amino acid sequencing. SPPS builds the peptide chain one amino acid at a time on a solid resin support. This sequential construction process allows chemists to verify each addition step, minimising truncated sequences, deletion products, and racemisation errors that would reduce purity and compromise compound identity.

The quality of synthesis at this stage directly determines the purity level achievable through subsequent purification. At Peptide Australia, we specify SPPS synthesis for every compound in our catalogue — there are no exceptions.

Stage 2 — Preparative HPLC Purification

Following synthesis, every batch undergoes preparative HPLC — a large-scale chromatographic purification process that isolates the target compound from synthesis byproducts, residual reagents, protecting group fragments, and any incomplete sequences produced during the synthesis process.

This purification stage is where the majority of impurities are removed. It is also the stage most commonly abbreviated or skipped by lower-quality suppliers seeking to reduce production costs. At Peptide Australia, preparative HPLC purification is non-negotiable. Without it, achieving ≥99% purity at the analytical verification stage is simply not possible.

Stage 3 — Analytical HPLC Verification

Following preparative purification, an aliquot from the production batch is submitted to an independent, accredited third-party laboratory for analytical HPLC verification. The laboratory runs the sample under validated chromatographic conditions and produces a chromatogram showing the purity profile of the batch.

The result must meet our minimum ≥99% threshold before the batch is approved for sale. Batches that fall below this threshold are rejected — they are not released for sale at a discounted purity level, and they are not relabelled. Consequently, every compound that appears in our catalogue and on this HPLC results page has met the ≥99% standard independently verified.

Stage 4 — Mass Spectrometry Identity Confirmation

Simultaneously with HPLC verification, every batch undergoes Mass Spectrometry analysis to confirm molecular weight and amino acid sequence identity. The MS result is cross-referenced against the theoretical molecular weight of the compound's specified sequence to confirm an exact match.

A batch that passes HPLC purity verification but fails MS identity confirmation is rejected. At Peptide Australia, both analytical tests must pass before a batch is approved. Therefore, every compound on our HPLC lab results page has passed both independent verification steps.

Stage 5 — Lyophilisation and Vacuum Sealing

Following analytical verification, every approved batch is lyophilised — freeze-dried — to remove residual moisture and maximise compound stability. The lyophilised powder is then vacuum-sealed in vials to prevent oxidation, moisture ingress, and degradation during transit and storage.

This packaging step is critical for ensuring that the purity result documented in the HPLC lab results and CoA reflects the compound condition at the point of receipt — not just at the point of manufacture. Furthermore, appropriate cold-chain packaging during dispatch maintains compound integrity throughout Australian delivery.

Stage 6 — Certificate of Analysis Generation

Following successful verification and packaging, a batch-specific Certificate of Analysis is generated for the production batch. The CoA documents the compound name, batch number, synthesis date, HPLC purity result, and Mass Spectrometry identity confirmation. This document is then linked to the batch number assigned to the vials dispatched from that production run.

When researchers receive their order, the batch number on their vials corresponds directly to the batch number on their CoA — and to the HPLC lab results published on this page. Consequently, every data point is fully traceable from the published analytical result back to the specific vials in the researcher's possession.

How to Read Our HPLC Chromatograms

For researchers less familiar with HPLC chromatogram interpretation, the following guide explains how to read the analytical data published on this page:

The X-Axis — Retention Time

The horizontal axis of an HPLC chromatogram represents retention time — the time elapsed from sample injection to compound detection at the detector. Different compounds travel through the HPLC column at different speeds depending on their chemical properties. Therefore, each compound in a mixture produces a peak at a characteristic retention time under a given set of chromatographic conditions.

For a high-purity research peptide, the chromatogram should show a single dominant peak at the retention time characteristic of the target compound. Additional smaller peaks — if present — represent impurities eluting at different retention times.

The Y-Axis — Signal Intensity

The vertical axis represents the intensity of the detector signal — typically measured in milliabsorbance units (mAU) for UV detectors. The height and area of each peak reflect the quantity of the corresponding compound present in the sample.

Purity Calculation

Purity is calculated by dividing the area of the target compound peak by the total area of all peaks in the chromatogram and multiplying by 100. Therefore, if the target compound peak accounts for 4,850 mAU·min of a total 4,900 mAU·min across all peaks, the calculated purity is 98.98% — which would fall just below our ≥99% threshold and result in batch rejection.

What to Look for in a High-Quality Chromatogram

A high-quality HPLC chromatogram for a research peptide meeting ≥99% purity shows the following characteristics. First, a single dominant peak with a clean, symmetrical shape — indicating a highly pure compound with minimal co-eluting impurities. Second, a flat, stable baseline before and after the main peak — indicating clean sample preparation and column conditioning. Third, either the complete absence of additional peaks, or very minor peaks with combined area totalling less than 1% of the total chromatogram area.

Our Published HPLC Results

Below you will find the HPLC chromatogram and Mass Spectrometry results for each compound currently available in the Peptide Australia catalogue. Results are organised by research category and updated with each new production batch. Every result displayed on this page corresponds to a current, in-stock batch — not historical or representative data.

[HPLC Results — Metabolic & Weight Loss Peptides]

• Retatrutide — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed
• AOD-9604 — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed
• GLP-1 Analog — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed
• 5-Amino-1-MQ — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed

[HPLC Results — Healing & Recovery Peptides]

• BPC-157 — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed
• TB-500 — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed
• TB-500 Fragment (17-23) — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed
• BPC-157 | GHK-Cu Combination — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed

[HPLC Results — Anti-Aging & Longevity Peptides]

• Epithalon — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed
• FOXO4-DRI — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed
• Thymagen — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed

[HPLC Results — Growth Hormone Peptides]

• CJC-1295 (no DAC) — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed
• Ipamorelin — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed
• Tesamorelin — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed
• Hexarelin — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed

[HPLC Results — Cognitive & Sleep Peptides]

• DSIP — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed
• Selank — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed
• Semax — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed

[HPLC Results — Skin Research Peptides]

• GHK-Cu — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed
• Melanotan-2 — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed

[HPLC Results — Sexual Health Peptides]

• PT-141 — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed

[HPLC Results — Hormonal Peptides]

• Tesamorelin — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed
• Thymagen — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed
• Epithalon — Batch [XXX] — Purity: ≥99.X% — MS: Confirmed

Note: Batch numbers and specific purity values are updated with each new production run. Contact our technical support team for the most current batch documentation for any specific compound.

Requesting a Certificate of Analysis

Every order dispatched by Peptide Australia includes a batch-specific Certificate of Analysis as standard. However, researchers who require CoA documentation prior to purchase — for institutional procurement approval, ethics committee requirements, or pre-order verification purposes — can request this documentation directly from our technical support team.

To request a Certificate of Analysis for a specific compound and batch, contact our team with the following information:

• Compound name
• Intended batch or current in-stock batch
• Institution or research facility name
• Researcher name and contact details

Our technical support team will provide the requested documentation promptly. Furthermore, researchers with ongoing supply requirements can arrange standing CoA provision as part of an institutional procurement agreement.

Third-Party Laboratory Accreditation

The analytical results published on this page are generated exclusively by independent, accredited third-party laboratories. Peptide Australia does not conduct in-house analytical testing and publish the results as independent verification — a practice that would represent a fundamental conflict of interest in analytical quality assurance.

Our third-party laboratory partners hold relevant accreditation under Australian and international analytical standards. Their instrumentation is calibrated and maintained to validated specifications. Their chromatographic methods are developed and validated specifically for peptide purity analysis. Consequently, the HPLC and Mass Spectrometry results published on this page represent genuine independent verification — not internal quality control claims presented as third-party data.

Frequently Asked Questions — HPLC Lab Results

Why does Peptide Australia publish its HPLC results publicly? We publish our HPLC lab results because we believe researchers deserve to verify the analytical claims of their suppliers independently — not simply accept them. Transparency in analytical documentation is the standard we hold ourselves to, and publishing our results publicly is the most direct expression of that commitment.

What does ≥99% HPLC purity mean for my research? A ≥99% HPLC purity result means that a minimum of 99% of the detected material in your compound sample is the target peptide. Consequently, any confounding effects from impurities are minimised to the greatest extent analytically achievable for research-grade peptide compounds.

How often are HPLC results updated on this page? HPLC results are updated with every new production batch. When a new batch of any compound enters our inventory, the corresponding HPLC chromatogram and MS result are published on this page and linked to the batch-specific CoA issued with orders from that batch.

Can I request HPLC data for a specific batch before placing an order? Yes. Contact our technical support team with the compound name and your institution details and we will provide the relevant HPLC and MS documentation for the current in-stock batch prior to purchase.

What happens if a batch fails the ≥99% HPLC threshold? Batches that fail to meet our ≥99% HPLC purity threshold are rejected and not released for sale under any circumstances. They are not sold at a reduced price, relabelled, or released with amended documentation. Consequently, every compound that appears in our catalogue and on this page has met our analytical standard independently.

The Peptide Australia Analytical Standard — A Summary

At Peptide Australia, analytical integrity underpins everything we do. Every compound in our catalogue passes through independent third-party HPLC purity verification and Mass Spectrometry identity confirmation before dispatch. Every batch result is documented in a batch-specific Certificate of Analysis. Furthermore, every result is published on this page for independent researcher review.

This is the standard Australian researchers deserve from their research peptide supplier. It is the standard Peptide Australia holds itself to — without exception.